Zobrazeno 1 - 10
of 14
pro vyhledávání: '"E N, Ignatova"'
Autor:
O. G. Starkova, E. N. Ovchinnikova, D. S. Tikhomirov, O. N. Misko, T. A. Soldatova, A. Yu. Krylova, E. N. Ignatova, T. A. Tupoleva, T. V. Gaponova
Publikováno v:
Russian journal of hematology and transfusiology. 67:492-499
Introduction. The new coronavirus infection COVID-19, fi rst detected at the end of 2019 in the Chinese city of Wuhan, caused a worldwide pandemic. High mortality among people with chronic diseases, a high frequency of the severe form of the disease,
Autor:
N. G. Yaroslavtseva, D. S. Tikhomirov, T. Yu. Romanova, E. N. Ignatova, T. A. Tupoleva, F. P. Filatov, T. V. Gaponova
Publikováno v:
Вопросы вирусологии, Vol 63, Iss 2, Pp 84-90 (2018)
Introduction. Human herpes virus type 6 (HHV 6) can cause serious infectious complications in immunodeficient patients. It is also capable of integrating into the genome of the infected cell. Due to this, there can be a misdiagnosis between viral int
Externí odkaz:
https://doaj.org/article/618b1113353c461796a9ec51f18a4d64
Autor:
E N Ignatova, T A Tupoleva, E N Ovchinnikova, T Yu Romanova, N G Yaroslavtseva, F P Filatov, V V Troitskaya, L A Kuzmina, E N Parovichnikova, T V Gaponova, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 11, Pp 27-34 (2017)
Aim. To evaluate the detection rate of markers for hepatitis B virus (HBV) in the blood samples taken from patients with blood system diseases, by applying the current approaches to examining donated blood and its components for markers of viral infe
Externí odkaz:
https://doaj.org/article/1c6b5ee88fd642328a3e68ecd712fa73
Publikováno v:
Вопросы вирусологии, Vol 61, Iss 6, Pp 280-284 (2016)
Data on hepatitis B (HBV) and c (HCV) viruses interference in hematological patients are described. Patients with a hematological malignancy are at high risk of HBV and HCV infection as recipients of multiple transfusions. Results of the laboratory t
Externí odkaz:
https://doaj.org/article/d971d1aabc39402e9a569c093f654a5b
Autor:
S. S. Bochkareva, A. G. Lyutov, V. S. Smirnov, Y. V. Kobzeva, E. V. Nazarenko, V. I. Lomonosova, N. M. Gracheva, L.I. Novikova, A. V. Aleshkin, E. I. Likhanskaya, A. A. Basov, A. A. Melnikova, E. N. Ignatova, B. M. Manuilov, A. M. Zatevalov, E. A. Shmeleva, M. N. Osadchaya, Elena E. Andreeva, Popova, A. Yu, Yezhlova, E. B., Areg A. Totolian, L. N. Antipova, Kombarova, S. Yu, Lyalina, L. V.
Publikováno v:
Infekcionnye bolezni. 18:8-16
The coronavirus disease pandemic (COVID-19) was announced by WHO in February 2020. In Moscow, the first case of the disease was detected on March 2, 2020 in a man who arrived from Italy. Two weeks after the first case, there was an exponential increa
Autor:
T A, Tupoleva, E N, Ignatova, A A, Gulyaeva, E N, Ovchinnikova, D S, Tikhomirov, R R, Abakarov, T Yu, Romanova, N G, Yaroslavtseva, O M, Koroleva, T A, Garanzha, F P, Filatov, T V, Gaponova, V G, Savchenko
Publikováno v:
Klinicheskaia laboratornaia diagnostika. 61(5)
Despite application of decreed modes of laboratory analysis of components of donors' blood, the risk of infection of recipients with hepatitis B virus continues to be actual. The isolated identification of HBsAg provides no control of all categories
Autor:
T A, Tupoleva, D S, Tikhomirov, L O, Grumbkova, E N, Ignatova, T Iu, Romanova, F P, Filatov, T A, Garanzha
Publikováno v:
Klinicheskaia laboratornaia diagnostika. 60(1)
The effect of statins occur in several stages: 1) inhibition in hepatocytes of synthesis of functionally specific pool of spirit cholesterol, polar mono-layer of lipoproteins of very low density; 2) activation of hydrolysis of triglycerides in lipopr
Autor:
N G, Yaroslavtseva, L O, Grumbkova, D S, Tikhomirov, E N, Ignatova, T Yu, Romanova, T A, Garanja, T A, Tupoleva, F P, Filatov
Publikováno v:
Klinicheskaia laboratornaia diagnostika. (6)
The extended monitoring (up to 1 year 11 months) of PCR markers was implemented concerning viral infections: cytomegalovirus, Epstein-Barr virus, simple herpes virus type I and II, hepatitis B virus, hepatitis C virus and bacterial infection of Helic
Autor:
N I, Simonova, I V, Niziaeva, S G, Nazarov, E A, Zhuravleva, N S, Kondrova, E G, Stepanov, R M, Fasikov, S M, Grigor'eva, E E, Andreeva, E N, Ignatova, A V, Tsyrulin, N N, Mazitova
Publikováno v:
Meditsina truda i promyshlennaia ekologiia. (1)
Comparative analysis covered three models of occupational risk evaluation: (1) Method to evaluate risks at workplace, elaborated in Finland and recommended by International Work Safety Agency for Eastern Europe and Central Asia countries; (2) Method
Autor:
D S, Tikhomirov, T A, Garanzha, V V, Troitskaia, P A, Suvorova, N G, Iaroslavtseva, T A, Tupoleva, L O, Grumbkova, E N, Ignatova, T Iu, Romanova, F P, Filatov, V G, Savchenko
Publikováno v:
Voprosy virusologii. 54(1)
The paper presents the results of monitoring the markers of herpes simplex viruses types 1 and 2, cytomegalovirus, Epstein-Barr virus, and human herpesvirus type 6 in the blood and bone marrow of patients with acute leukemias during induction multidr